Dr. Erik Holmlin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Erik Holmlin
Earlier roles on record: CEO at Bionano Genomics, Inc. (BNGO) until May 5, 2026. Bionano Genomics, Inc. reported in an 8-K filed May 6, 2026 that Dr. Erik Holmlin resigned as Board of Directors, effective May 5, 2026. Dr. Erik Holmlin has spoken on 1 earnings call across 1 company, most recently for Bionano Genomics, Inc. on November 12, 2020.
“In connection with his termination, Dr. Holmlin resigned from the Company's Board of Directors (the "Board") and any committees thereof, effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2026-05-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.